Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
Scientists discover the ‘roadmap’ that aggressive cancer uses to spread around the body
Scientists have discovered a new way to predict which tumours will become aggressive before they…
Text message tool addresses “time toxicity” for cancer patients
Cancer patients spend a lot of time on their care. Meeting with doctors and other…
The US Leukemia & Lymphoma society denounces government actions that threaten cancer patients
Statement from the US Leukemia & Lymphoma Society As the nation’s largest organisation serving the…
New therapeutic strategy for metastatic prostate cancer patients resistant to standard treatment
- Increase in annual cardiorespiratory fitness by 3%+ linked to 35% lower prostate cancer risk
- What factors affect patients’ decisions regarding active surveillance for low-risk prostate cancer?
- Primary care physicians and urologists work together to provide optimal care for men with low-risk prostate cancer
Researchers develop biomarker algorithm for noninvasive detection of Barrett’s oesophagus and oesophageal cancer
- Study reveals unique features of early onset colorectal cancer in racial and ethnic minorities
- Dronedarone inhibits the proliferation of esophageal squamous cell carcinoma through the CDK4/CDK6-RB1 axis in vitro and in vivo
- Polymorphism in the Hsa-miR-4274 seed region influences the expression of PEX5 and enhances radiotherapy resistance in colorectal cancer
9/11 firefighters may have more mutations in their blood
First responders to the 9/11 attacks have an increased number of mutations in their blood that may predispose them to…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.